DUBLIN--(BUSINESS WIRE)--May. 29, 2013--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the Jefferies 2013 Global Healthcare Conference
on Monday, June 3, 2013, at 11:30 a.m. EDT (4:30 p.m. BST) from the
Grand Hyatt Hotel in New York City. In addition, Alkermes’ corporate
presentation will be webcast live at the Goldman Sachs 34th
Annual Global Healthcare Conference on Tuesday, June 11, 2013, at 8:00
a.m. PDT (11:00 a.m. EDT/4:00 p.m. BST) from the Terranea Resort in
Rancho Palos Verdes, Calif. These presentations may be accessed under
the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate
Communications
